EP 1597582 A2 20051123 - DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN ENDOTHELIAL DIFFERENTIATION, SPHINGOLIPID G-PROTEIN-COUPLED RECEPTOR 3 (EDG3)
Title (en)
DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN ENDOTHELIAL DIFFERENTIATION, SPHINGOLIPID G-PROTEIN-COUPLED RECEPTOR 3 (EDG3)
Title (de)
DIAGNOSTISCHE UND THERAPEUTISCHE MITTEL FÜR KRANKHEITEN, DIE MIT HUMAN ENDOTHELIAL DIFFERENTIATION, SPHINGOLIPID G-PROTEIN-COUPLED RECEPTOR 3 (EDG3) ASSOZIIERT SIND
Title (fr)
AGENTS DIAGNOSTIQUES ET THERAPEUTIQUES DESTINES A DES MALADIES ASSOCIEES AU RECEPTEUR 3 COUPLE A UNE PROTEINE G SPHINGOLIPIDE DE DIFFERENCIATION ENDOTHELIALE HUMAIN (EDG3)
Publication
Application
Priority
- EP 0312120 W 20031031
- EP 02025501 A 20021113
- EP 03779825 A 20031031
Abstract (en)
[origin: WO2004044589A2] The invention provides a human EDG3 which is associated with the hematological diseases, cardiovascular diseases, disorders of the peripheral and central nervous system, urology diseases, cancer diseases. The invention also provides assays for the identification of compounds useful in the treatment or prevention of hematological diseases, cardiovascular diseases, disorders of the peripheral and central nervous system, urology diseases, cancer diseases. The invention also features compounds which bind to and/or activate or inhibit the activity of EDG3 as well as pharmaceutical compositions comprising such compounds.
IPC 1-7
IPC 8 full level
A61K 38/00 (2006.01); A61K 38/43 (2006.01); G01N 33/573 (2006.01); G01N 33/92 (2006.01)
CPC (source: EP)
G01N 33/92 (2013.01)
Citation (search report)
See references of WO 2004044589A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2004044589 A2 20040527; WO 2004044589 A3 20040617; AU 2003287976 A1 20040603; EP 1597582 A2 20051123
DOCDB simple family (application)
EP 0312120 W 20031031; AU 2003287976 A 20031031; EP 03779825 A 20031031